Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast medium

American Journal of Nephrology

Volumn 33, Issue 2, 2011, Pages 176-184

  Mignani, Renzo ^a   Corsi, Cristiana ^c   De Marco, Mariangela ^c   Caiani, Enrico G ^b   Santucci, Gioele ^a   Cavagna, Enrico ^a   Severi, Stefano ^c   Cagnoli, Leonardo ^a  

^a Infermi Hospital   (Italy)

^b POLITECNICO DI MILANO   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autosomal dominant polycystic kidney disease; Chronic kidney disease; Magnetic resonance imaging; Renal volume

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; AUTOMATION; CLINICAL ARTICLE; FEMALE; HUMAN; KIDNEY; KIDNEY POLYCYSTIC DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PHANTOM; PRIORITY JOURNAL; STEREOLOGY; TOTAL RENAL VOLUME;

ADULT; AGED; AUTOMATION; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHANTOMS, IMAGING; POLYCYSTIC KIDNEY DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; REGRESSION ANALYSIS;

EID: 79751536179     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324039     Document Type: Article

References (26)

1. Gabow PA, Johnson AM, Kaehny WD, et al: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-1319.
2. Bae KT, Tao C, Zhu F, Bost JE, Chapman AB, Grantham JJ, Torres VE, Guay-Woodford LM, Meyers CM, Bennett WM and the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): MRIbased kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol 2009; 4: 719-725.
3. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP and the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magnetic resonance imaging evaluation of hepatic cysts in early autosomaldominant polycystic kidney disease: polycystic kidney disease cohort. Clin J Am Soc Nephrol 2006; 1: 64-69.
4. Grantham JJ, Cook LT, Torres VE, Bost JE, Chapman AB, Harris PC, Guay-Woodford LM, Bae KT, for the CRISP Investigators: Determinants of renal volume in autosomaldominant polycystic kidney disease. Kidney Int 2008; 73: 108-116. (Pubitemid 350273644)
5. Grantham JJ, Torre VR, Chapman AB, Guay- Woodford LM, Bae KT, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Mayers CM, Zhang X, Zhu F, Miller JP: Volume progression in PKD. N Engl J Med 2006; 354: 2122-2130.
6. Perrone R: Imaging progression in polycystic kidney disease. N Engl J Med 2006; 354: 2181-2183. (Pubitemid 43736620)
7. Sise C, Kusaka M, Wetzel LH, Winklhofer F, Cowley BD, Cook LT, Gordon M, Grantham JJ: Volumetric determination of progression in autosomal-dominant polycystic kidney disease by computed tomography. Kidney Int 2000; 58: 2492-2501.
8. King BF, Reed JE, Bergstralh EJ, Sheedy PF, Torres VE: Quantification and longitudinal trends of kidney, renal cyst and renal parenchyma volumes in autosomal polycystic kidney disease. J Am Soc Nephrol 2000; 11: 1505-1511. (Pubitemid 30483467)
9. Antiga L, Piccinelli M, Fasolini G, Ene- Iordache B, Ondei P, Bruno S, Remuzzi G, Remuzzi A: Computed tomography evaluation of autosomal-dominant polycystic kidney disease progression: a progress report. Clin J Am Soc Nephrol 2006; 1: 754-760.
10. Lee YR, Lee KB: Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function. Nephron Clin Pract 2006; 103:c173-c180.
11. Reichardt W, Romaker D, Becker A, Buechert M, Walz G, von Elverfeldt D: Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin-treated mouse model of ADPKD. MAGMA 2009; 22: 143-149.
12. Kistler AD, Poster D, Krauer F, Weishaupt D, Raina S, Senn O, Binet I, Spanaus K, Wuthrich RP, Serra AL: Increases in kidney volume in autosomal-dominant polycystic kidney disease can be detected within 6 months. Kidney Int 2009; 75: 235-241.
13. Natalin RA, Prince MR, Grossman ME, Silvers D, Landman J: Contemporary applications and limitations of magnetic resonance imaging contrast materials. J Urol 2010; 183: 27-33.
14. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VR, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin MI, Bennett WM, Klahr S, Hirschman GH, Kimmel PI, Thompson PA, Miller JP: Renal structure in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 2003; 64: 1035-1045. (Pubitemid 37013840)
15. Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Arlene B, Chapman AB, Guay- Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang Q, Thompson PA, Zhu F, Miller JP and the CRISP: Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal-dominant polycystic kidney disease. J Am Soc Nephrol 2006; 17: 3013-3019. (Pubitemid 44707761)
16. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP and the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magnetic resonance measurements of renal blood flow and disease progression in autosomal- dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 112-120.
17. Mitchell MD, Kundel HL, Axel L, Joseph PM: Agarose as a tissue equivalent phantom material for NMR imaging. Magn Reson Imaging 1986; 4: 263-266. (Pubitemid 16098667)
18. Bae KT, Commean PK, Lee J: Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr 2000; 24: 614-619. (Pubitemid 32204335)
19. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal-dominant polycystic kidney disease. Lancet 1994; 343: 824-827. (Pubitemid 24147512)
20. Zucker SW: Region growing: childhood and adolescence. Comput Graph Image Process 1976; 5: 382-399.
21. Sethian JA: Level Set Methods and Fast Marching Methods. Cambridge, Cambridge University Press, 1999.
22. Schiller NB, Shah PM, Crawford M, De- Maria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
23. Roberts N, Puddephat MJ, McNulty V: The benefit of stereology for quantitative radiology. Br J Radiol 2000; 73: 679-697. (Pubitemid 30614222)
24. Bae KT, Grantham JJ: Imaging for the prognosis of autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2010; 6: 96-106.
25. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wüthrich RP: Sirolimus and kidney growth in autosomal-dominant polycystic kidney disease. N Engl J Med N Engl J Med 2010; 363: 820-829.
26. Watnick T, Germino GG: mTOR inhibitors in polycystic kidney disease. N Engl J Med 2010; 363: 879-881.